These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 37449200)

  • 21. Oral manifestations compatible with chronic graft-versus-host disease in patients with Fanconi anemia.
    Grein Cavalcanti L; Fuentes Araújo RL; Bonfim C; Torres-Pereira CC
    Biol Blood Marrow Transplant; 2015 Feb; 21(2):275-80. PubMed ID: 25316110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral chronic graft-versus-host disease in pediatric patients after hematopoietic stem cell transplantation.
    Treister NS; Woo SB; O'Holleran EW; Lehmann LE; Parsons SK; Guinan EC
    Biol Blood Marrow Transplant; 2005 Sep; 11(9):721-31. PubMed ID: 16125643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence and Outcome of Atypical Manifestations of Chronic Graft-versus-Host Disease: Results From a Retrospective Single-Center Analysis.
    Doering J; Perl M; Weber D; Banas B; Schulz C; Hamer OW; Angstwurm K; Holler E; Herr W; Edinger M; Wolff D; Fante MA
    Transplant Cell Ther; 2023 Dec; 29(12):772.e1-772.e10. PubMed ID: 37777112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral chronic graft-versus-host disease: What the general dental practitioner needs to know.
    Haverman TM; Raber-Durlacher JE; Raghoebar II; Rademacher WMH; Rozema FR; Hazenberg MD; Epstein JB; Treister NS
    J Am Dent Assoc; 2020 Nov; 151(11):846-856. PubMed ID: 33121606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Phase I Trial of SYK Inhibition with Fostamatinib in the Prevention and Treatment of Chronic Graft-Versus-Host Disease.
    Lin C; DiCioccio RA; Haykal T; McManigle WC; Li Z; Anand SM; Poe JC; Bracken SJ; Jia W; Alyea EP; Cardones AR; Choi T; Gasparetto C; Grunwald MR; Hennig T; Kang Y; Long GD; Lopez R; Martin M; Minor KK; Quinones VLP; Sung AD; Wiggins K; Chao NJ; Horwitz ME; Rizzieri DA; Sarantopoulos S
    Transplant Cell Ther; 2023 Mar; 29(3):179.e1-179.e10. PubMed ID: 36577483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistopathological study of the oral lichenoid lesions of chronic GVHD.
    Sato M; Tokuda N; Fukumoto T; Mano T; Sato T; Ueyama Y
    J Oral Pathol Med; 2006 Jan; 35(1):33-6. PubMed ID: 16393251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral symptom intensity, health-related quality of life, and correlative salivary cytokines in adult survivors of hematopoietic stem cell transplantation with oral chronic graft-versus-host disease.
    Fall-Dickson JM; Mitchell SA; Marden S; Ramsay ES; Guadagnini JP; Wu T; St John L; Pavletic SZ;
    Biol Blood Marrow Transplant; 2010 Jul; 16(7):948-956. PubMed ID: 20139026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significance of oral examination in chronic graft-versus-host disease.
    Hiroki A; Nakamura S; Shinohara M; Oka M
    J Oral Pathol Med; 1994 May; 23(5):209-15. PubMed ID: 8046658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lichenoid sialadenitis in chronic graft versus host disease.
    Piacenza Florezi G; Monteiro de Souza M; Ducati Dabronzo ML; Batista Bologna S; Menta Simonsen M; Lourenço SV
    Dermatol Online J; 2020 Dec; 26(12):. PubMed ID: 33423424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and Safety of Ibrutinib for Chronic Graft-Versus-Host Disease: A Systematic Review.
    Santosa D; Rizky D; Tandarto K; Kartiyani I; Yunarvika V; Ardini DNE; Setiawan B; Pangarsa EA; Suharti C
    Asian Pac J Cancer Prev; 2023 Dec; 24(12):4025-4033. PubMed ID: 38156834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extensive dental caries in patients with oral chronic graft-versus-host disease.
    Castellarin P; Stevenson K; Biasotto M; Yuan A; Woo SB; Treister NS
    Biol Blood Marrow Transplant; 2012 Oct; 18(10):1573-9. PubMed ID: 22516054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell Therapy Transplant Canada (CTTC) Consensus-Based Guideline 2024 for Management and Treatment of Chronic Graft-Versus-Host Disease and Future Directions for Development.
    Kim DDH; Popradi G; Lepic K; Paulson K; Allan D; Nampoothiri RV; Lachance S; Deotare U; White J; Elemary M; Jamani K; Fraga C; Lemieux C; Novitzky-Basso I; Law AD; Kumar R; Walker I; Schultz KR;
    Curr Oncol; 2024 Mar; 31(3):1426-1444. PubMed ID: 38534941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Grading of minor salivary gland immuno-histopathology post-allogenic hematopoietic cell transplantation.
    Tollemar V; Arvidsson H; Häbel H; Tudzarovski N; Legert KG; Le Blanc K; Warfvinge G; Sugars RV
    Heliyon; 2023 Apr; 9(4):e15517. PubMed ID: 37128306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Oral chronic graft versus host disease, what is it and how is it treated?].
    Laheij AMGA; Raber-Durlacher JE; Hazenberg MD; Schoordijk MCE; Huysmans MCDNJM; de Visscher JGAM
    Ned Tijdschr Tandheelkd; 2022 Jul; 129(7-8):329-336. PubMed ID: 35833281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic graft-versus-host disease in pediatric patients: Differences and challenges.
    Haroun E; Agrawal K; Leibovitch J; Kassab J; Zoghbi M; Dutta D; Lim SH
    Blood Rev; 2023 Jul; 60():101054. PubMed ID: 36805299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting Bcl-6 prevents sclerodermatous chronic graft-versus-host disease by abrogating T follicular helper differentiation in mice.
    Chen X; Wang Y; Huang X; Geng S; Li C; Zeng L; Huang L; Du X; Weng J; Lai P
    Int Immunopharmacol; 2023 Apr; 117():109746. PubMed ID: 36827923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic GvHD NIH Consensus Project Biology Task Force: evolving path to personalized treatment of chronic GvHD.
    Buxbaum NP; Socié G; Hill GR; MacDonald KPA; Tkachev V; Teshima T; Lee SJ; Ritz J; Sarantopoulos S; Luznik L; Zeng D; Paczesny S; Martin PJ; Pavletic SZ; Schultz KR; Blazar BR
    Blood Adv; 2023 Sep; 7(17):4886-4902. PubMed ID: 36322878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteomic analysis of saliva from patients with oral chronic graft-versus-host disease.
    Devic I; Shi M; Schubert MM; Lloid M; Izutsu KT; Pan C; Missaghi M; Morton TH; Mancl LA; Zhang J; Presland RB
    Biol Blood Marrow Transplant; 2014 Jul; 20(7):1048-55. PubMed ID: 24704387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic graft versus host disease of oral mucosa: review of available therapies.
    Imanguli MM; Pavletic SZ; Guadagnini JP; Brahim JS; Atkinson JC
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Feb; 101(2):175-83. PubMed ID: 16448918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral chronic graft-vs.-host disease characterization using the NIH scale.
    Fassil H; Bassim CW; Mays J; Edwards D; Baird K; Steinberg SM; Williams KM; Cowen EW; Mitchell SA; Hakim FT; Taylor T; Avila D; Zhang D; Grkovic L; Datiles M; Gress RE; Pavletic SZ
    J Dent Res; 2012 Jul; 91(7 Suppl):45S-51S. PubMed ID: 22699667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.